A new report for glycosylated hemoglobin: The future is here;Un nuovo referto per l'emoglobina glicata: Il futuro è qui

Biochimica Clinica

Volumn 34, Issue 2, 2010, Pages 93-95

  Panteghini, Mauro ^a  

^a UNIVERSITY OF MILAN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; GLYCOSYLATED HEMOGLOBIN; HEMOGLOBIN A1C;

CLINICAL PROTOCOL; DIABETES MELLITUS; DIAGNOSTIC TEST; EDITORIAL; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE TEST; HEMOGLOBIN BLOOD LEVEL; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; LABORATORY TEST; LONG TERM CARE; METABOLIC REGULATION; PROSPECTIVE STUDY; RISK FACTOR; UNITED KINGDOM;

EID: 77957688116     PISSN: 03930564     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Editorial

References (15)

1. Mosca A. Avanzamenti nella misura e nell'utilizzo clinico dell'emoglobina glicata. Biochim Clin 2006;30:487-92.
2. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993;329:977-86.
3. UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998;352:837-53.
4. American Diabetes Association. Standards of medical care in diabetes-2010. Diabetes Care 2010;33(suppl 1):S11-61.
5. The International Expert Committee. International expert committee report on the role of the A1C assay in the diagnosis of diabetes. Diabetes Care 2009;32:1327-34.
6. Hicks J, Muller M, Panteghini M, et al. Consensus statement on the worldwide standardization of the hemoglobin A1C measurement. Diabetes Care 2007;30;2399-400.
7. Hicks J, Muller M, Panteghini M, et al. Consensus statement on the worldwide standardization of the hemoglobin A1c measurement. Diabetologia 2007;50;2042-3.
8. Hicks J, Muller M, Panteghini M, et al. American Diabetes Association (ADA), European Association for the Study of Diabetes (EASD), International Federation of Clinical Chemistry and Laboratory Medicine (IFCC) and International Diabetes Federation (IDF) consensus statement on the worldwide standardization of the hemoglobin A1c measurement. Biochim Clin 2007;31:359-60.
9. 1c measurement. Clin Chem Lab Med 2008;46:573-4.
10. Mosca A, Branca MT, Carta M, et al. Raccomandazioni per l'implementazione della standardizzazione internazionale della misura dell'emoglobina glicata in Italia. Biochim Clin 2009;33:258-61.
11. Weykamp C, John WG, Mosca A, et al. The IFCC reference measurement system for HbA1c: A 6-year progress report. Clin Chem 2008;54:240-8. (Pubitemid 351302616)
12. Panteghini M, John WG. Implementation of haemoglobin A1c results traceable to the IFCC reference system: the way forward. Clin Chem Lab Med 2007;45:942-4. (Pubitemid 47424863)
13. Panteghini M. Traceability, reference systems and result comparability. Biochim Clin 2007;31:247-53.
14. Geistanger A, Arends S, Berding C, et al. on behalf of the IFCC Working Group on Standardization of Hemoglobin A1c. Statistical methods for monitoring the relationship between the IFCC reference measurement procedure for hemoglobin A1c and the designated comparison methods in the United States, Japan, and Sweden. Clin Chem 2008;54:1379-85.
15. Ceriotti F, Panteghini M. "I risultati dei miei esami sono normali?": considerazioni su intervalli di riferimento e livelli decisionali. Biochim Clin 2009;33:229-33.